Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7
Holding DE:RV7?
Track your performance easily

Halozyme (RV7) Balance Sheet

2 Followers

Halozyme Balance Sheet

Halozyme's total assets for Q2 2024 were $1.97B, an increase of 6.95% from the previous quarter. DE:RV7 total liabilities were $1.68B for the fiscal quarter, a 0.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.73B$ 1.84B$ 1.10B$ 579.92M$ 565.87M
Total Liabilities
$ 1.65B$ 1.67B$ 907.48M$ 428.88M$ 474.11M
Total Equity Gross Minority
$ 83.81M$ 169.80M$ 196.95M$ 151.05M$ 91.77M
Total Capitalization
$ 3.08B$ 3.17B$ 1.86B$ 151.05M$ 474.81M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Halozyme Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis